Use of <i>Ephedra</i> -containing products and risk for hemorrhagic stroke

Lewis B. Morgenstern, Catherine M. Viscoli, Walter N. Kernan, Lawrence Brass, J. P. Broderick, Edward Feldmann, Janet L. Wilterdink, Thomas Brott, Ralph I. Horwitz

Neurology · 2003 · 81 citations · 10 references

Concepts

Abstract

This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of < or =32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.

References

10